Education
About Us
Working with TipRanks
Follow Us
Benson Hill (BHILQ)
OTHER OTC:BHILQ
Top Page
Benson Hill
(OTC:BHILQ)
Select Model
Select Model
Rating:39Underperform
Price Target:―
Benson Hill's stock score reflects significant financial challenges, including declining revenues and high leverage, which are the primary concerns. The technical analysis does not show signs of recovery, and the negative valuation metrics further contribute to the low score. Improvements in cash flow management are noted but are insufficient to offset the broader financial instability.
Benson Hill (BHILQ) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$611.00
Dividend YieldN/A
Average Volume (3M)6.01K
Price to Earnings (P/E)―
Beta (1Y)1.78
Revenue GrowthN/A
EPS GrowthN/A
CountryUS
Employees270
SectorBasic Materials
Sector Strength58
IndustryAgricultural Inputs
Share Statistics
EPS (TTM)N/A
Shares Outstanding6,114,020
10 Day Avg. Volume6,117
30 Day Avg. Volume6,006
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Benson Hill Business Overview & Revenue Model
Company DescriptionBenson Hill, Inc., together with its subsidiaries, operates as a food technology company that unlocks natural genetic diversity of plants. It operates in two segments, Ingredients and Fresh. The company offers CropOS, a technology platform, which uses artificial intelligence, data, and various advanced breeding techniques that combine data, plant, and food sciences to deliver crops optimized for food, ingredient, and feed products. The company's technology is applied in soybeans and yellow peas. It focuses on growing, packing, and selling fresh produce products to retail and food service customers. The company was formerly known as Benson Hill Biosystems, Inc. Benson Hill, Inc. was incorporated in 2012 and is headquartered in Saint Louis, Missouri.
How the Company Makes MoneyBenson Hill generates revenue primarily through its proprietary CropOS platform and its associated plant breeding and biotechnology services. The company earns money by developing and licensing improved crop varieties, which are designed to enhance yield, nutritional content, and sustainability. Additionally, Benson Hill partners with agricultural companies, food manufacturers, and ingredient suppliers to co-develop tailored crop solutions. Revenue streams also include direct sales of seeds and plant-based ingredients to food producers and processors. Strategic partnerships and collaborations with industry leaders further bolster its financial performance by expanding market reach and accelerating innovation.
Benson Hill Earnings Call Summary
Earnings Call Date:Aug 06, 2025
(Q4-2023)
| % Change Since: |
Next Earnings Date:Nov 18, 2025
Earnings Call Sentiment Neutral
The earnings call presented significant achievements such as revenue growth, debt reduction, and cost-cutting success, positioning the company for future opportunities. However, challenges remain with goodwill impairment, expected revenue decline in 2024 due to asset divestitures, and concerns over cash burn. The company is in a transition phase, focusing on leveraging its technology and strategic partnerships.Q4-2023 Updates
Positive Updates
Revenue Growth
Benson Hill reported consolidated revenues of $473 million, a 24% year-over-year improvement, driven by a 52% revenue growth in proprietary and 18% growth in nonproprietary grain products.
Debt Reduction
The company retired its senior term loan, representing approximately $120 million in debt plus interest and fees, ending the year with approximately $49 million in cash.
Cost-Cutting Success
Benson Hill restructured its organization and reduced recurring OpEx and CapEx by more than 33%, achieving significant cost savings.
Expansion in Soy Segments
The company is on track to expand its seed portfolio from 22 to 35 varieties by 2025, leveraging its advanced soy genetics toolbox.
Negative Updates
Goodwill Impairment and Nonrecurring Costs
Total operating expenses included $19 million in goodwill impairment and $13 million in net charges related to nonrecurring severance and other costs.
2024 Revenue Decline
Expected lower revenue in 2024 due to the divestiture of soy processing assets and transition to a new business model.
Cash Burn Concerns
Free cash use was $87 million, including onetime cash costs of approximately $16 million, with ongoing efforts needed to reduce cash burn further.
Company Guidance
During the Benson Hill Q4 2023 earnings call, management provided a comprehensive update on the company's strategic initiatives and financial performance metrics. The company reported consolidated revenues of $473 million for 2023, marking a 24% year-over-year improvement, with proprietary grain products growing by 52% and nonproprietary grain products by 18%. Gross profit reached $23 million, more than tripling the prior year's figure, while adjusted EBITDA showed a loss of $48 million, improved by over 40% from the previous year. The company successfully reduced recurring operating expenses (OpEx) and capital expenditures (CapEx) by more than 33% and ended the year with approximately $49 million in cash. Looking ahead to 2024, Benson Hill aims to transition to an asset-light business model, focusing on strategic partnerships and licensing deals. While revenues are expected to decline due to recent asset divestitures, the company anticipates enhancing earnings quality and reducing cash burn. Key performance areas for 2024 include transitioning from the legacy business model, improving operating margins, securing partnerships, optimizing capital structure, and expanding its intellectual property and technology pipeline.Benson Hill Financial Statement Overview
Summary
Income Statement
35
Negative
Balance Sheet
40
Negative
Cash Flow
45
Neutral
| Breakdown |
|---|
Income Statement |
| Total Revenue |
| Gross Profit |
| EBITDA |
| Net Income |
Balance Sheet |
| Total Assets |
| Cash, Cash Equivalents and Short-Term Investments |
| Total Debt |
| Total Liabilities |
| Stockholders Equity |
Cash Flow |
| Free Cash Flow |
| Operating Cash Flow |
| Investing Cash Flow |
| Financing Cash Flow |
Benson Hill Technical Analysis
Negative
0.01
Price Trends
0.03
Negative
0.16
Negative
1.92
Negative
Market Momentum
>-0.01
Negative
39.07
Neutral
-5.56
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For BHILQ, the sentiment is Negative. The current price of 0.01 is below the 20-day moving average (MA) of 0.02, below the 50-day MA of 0.03, and below the 200-day MA of 1.92, indicating a bearish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 39.07 is Neutral, neither overbought nor oversold. The STOCH value of -5.56 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for BHILQ.
Benson Hill Risk Analysis
Benson Hill disclosed 59 risk factors in its most recent earnings report. Benson Hill reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Benson Hill Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| ― | $120.40M | -2.34 | ― | ― | -28.28% | -1718.93% | |
| ― | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
| ― | $5.07M | -0.67 | -87.18% | ― | 1.50% | -8.01% | |
| ― | $12.74M | -26.66 | ― | ― | -21.82% | -104.92% | |
| ― | $166.12M | ― | ― | ― | ― | ― | |
| ― | $139.31M | ― | -42.97% | ― | -9.57% | -3226.39% | |
| ― | $611.00 | ― | ― | ― | ― | ― |
* Basic Materials Sector Average
BHILQ
Benson Hill
0.01
-6.81
-99.85%
AVD
American Vanguard
4.59
-0.64
-12.24%
SEED
Origin Agritech
1.77
-0.77
-30.31%
RKDA
Arcadia Biosciences
3.71
-0.14
-3.64%
BIOX
Bioceres Crop Solutions
1.92
-4.80
-71.43%
LVRO
Lavoro Limited
1.38
-2.62
-65.50%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.